GCP
ORGO icon

GSA Capital Partners’s Organogenesis Holdings ORGO Stock Holding History

GSA Capital Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-155,869
Closed -$369K – 2051
2026
Q1 		$369K Sell
155,869
-35,596
-19% -$123K 0.02% 1113
2025
Q4 		$992K Buy
+191,465
New +$928K 0.09% 364
2025
Q3 		– Sell
-79,024
Closed -$289K – 1973
2025
Q2 		$289K Buy
+79,024
New +$295K 0.02% 1279
2025
Q1 		– Sell
-354,154
Closed -$1.13M – 1963
2024
Q4 		$1.13M Sell
354,154
-419,393
-54% -$1.41M 0.08% 326
2024
Q3 		$2.21M Sell
773,547
-111,174
-13% -$312K 0.17% 96
2024
Q2 		$2.48M Buy
884,721
+353,503
+67% +$949K 0.17% 86
2024
Q1 		$1.51M Buy
531,218
+269,315
+103% +$915K 0.12% 219
2023
Q4 		$1.07M Sell
261,903
-352,665
-57% -$988K 0.09% 356
2023
Q3 		$1.95M Sell
614,568
-94,642
-13% -$301K 0.17% 115
2023
Q2 		$2.35M Sell
709,210
-16,348
-2% -$48.3K 0.24% 30
2023
Q1 		$1.54M Buy
725,558
+522,162
+257% +$1.29M 0.15% 141
2022
Q4 		$547K Buy
203,396
+191,407
+1,597% +$558K 0.07% 548
2022
Q3 		$39K Sell
11,989
-22,391
-65% -$101K 0.01% 1435
2022
Q2 		$168K Buy
34,380
+21,530
+168% +$133K 0.03% 1114
2022
Q1 		$98K Buy
+12,850
New +$99.5K 0.01% 1297
2020
Q4 		– Sell
-16,953
Closed -$65K – 1499
2020
Q3 		$65K Buy
+16,953
New +$66.9K 0.01% 1170

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GSA Capital Partners's ORGO Position: Q2 2026 in Review

GSA Capital Partners sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 155,869 shares — an estimated $369K sold.

GSA Capital Partners first reported a position in ORGO in Q3 2020 and held it in 16 quarters. The position peaked at $2.48M in Q2 2024. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • GSA Capital Partners reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 155,869 Organogenesis Holdings shares in Q2 2026, an estimated $369K.
  • GSA Capital Partners first reported a position in Organogenesis Holdings in Q3 2020 and held it in 16 quarters.
  • GSA Capital Partners's Organogenesis Holdings position peaked at $2.48M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.